Carsten Rudolph is the founder of ethris. ethris has raised $26M in total funding. Latest round: Series B. Based in Munich, Germany.
Carsten Rudolph, PhD, is the CEO of ethris GmbH, a biotechnology company developing room-temperature-stable mRNA therapies for respiratory diseases. He has led the company through the validation of its platform in humans and healthy volunteers, with asthma as the first indication. Rudolph has also represented ethris in research alliances.
Full founder directory · Investor directory · Company funding database · Fundraising library